Acquired Long QT Syndrome

被引:16
作者
Marzuillo, Pierluigi [1 ]
Benettoni, Alessandra [2 ]
Germani, Claudio [2 ]
Ferrara, Giovanna [2 ]
D'Agata, Biancamaria [2 ]
Barbi, Egidio [2 ]
机构
[1] Univ Naples 2, Dept Women & Children & Gen & Specialized Surg, I-80138 Naples, Italy
[2] Univ Trieste, Inst Maternal & Child Hlth IRCCS, Trieste, Italy
关键词
acquired long QT syndrome; torsade de pointes; syncope; drugs prolonging QT; TORSADES-DE-POINTES; DRUG-THERAPY; PROLONGATION; INTERVAL; POTASSIUM; MODULATION; DEPENDENCE;
D O I
10.1097/PEC.0000000000000108
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acquired long QT syndrome (LQTS) is a disorder of cardiac repolarization most often due to specific drugs, hypokalemia, or hypomagnesemia that may precipitate torsade de pointes and cause sudden cardiac death. Common presentations of the LQTS are palpitations, presyncope, syncope, cardiac arrest, and seizures. An abnormal 12-lead electrocardiogram obtained while the patient is at rest is the key to diagnosis. The occurrence of drug-induced LQTS is unpredictable in any given individual, but a common observation is that most patients have at least 1 identifiable risk factor in addition to drug exposure. The cornerstone of the management of acquired LQTS includes the identification and discontinuation of any precipitating drug and the correction of metabolic abnormalities, such as hypokalemia or hypomagnesemia. Most of the episodes of torsade de pointes are short-lived and terminate spontaneously. We propose a management protocol that could be useful for the daily practice in the emergency pediatric department to reduce the risk of acquired QT prolongation.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 28 条
  • [1] [Anonymous], 2011, BNF CHILDR 2011 2012
  • [2] Voriconazole-induced QT interval prolongation and torsades de pointes
    Aypar, Ebru
    Kendirli, Tanil
    Tutar, Ercan
    Ciftci, Ergin
    Ince, Erdal
    Ileri, Talia
    Atalay, Semra
    [J]. PEDIATRICS INTERNATIONAL, 2011, 53 (05) : 761 - 763
  • [3] DRUG-THERAPY FOR TORSADE-DE-POINTES
    BANAI, S
    TZIVONI, D
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1993, 4 (02) : 206 - 210
  • [4] Choy AM, 1997, CIRCULATION, V96, P2149
  • [5] Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole
    Esch, Jesse J.
    Kantoch, Michal J.
    [J]. PEDIATRIC CARDIOLOGY, 2008, 29 (01) : 210 - 213
  • [6] Rates of Torsades de Pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin
    Frothingham, R
    [J]. PHARMACOTHERAPY, 2001, 21 (12): : 1468 - 1472
  • [7] Clarithromycin treatment and QT prolongation in childhood
    Germanakis, Ioannis
    Galanakis, Emmanouil
    Parthenakis, Fragiskos
    Vardas, Panos E.
    Kalmanti, Maria
    [J]. ACTA PAEDIATRICA, 2006, 95 (12) : 1694 - 1696
  • [8] AZITHROMYCIN AND TERFENADINE - LACK OF DRUG-INTERACTION
    HARRIS, S
    HILLIGOSS, DM
    COLANGELO, PM
    ELLER, M
    OKERHOLM, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (03) : 310 - 315
  • [9] Bazett and Fridericia OT correction formulas interfere with measurement of drug-induced changes in QT interval
    Indik, Jutia H.
    Pearson, Elen C.
    Fried, Karen
    Woosley, Raymond L.
    [J]. HEART RHYTHM, 2006, 3 (09) : 1003 - 1007
  • [10] Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy
    Johnson, J. N.
    Hofman, N.
    Haglund, C. M.
    Cascino, G. D.
    Wilde, A. A. M.
    Ackerman, M. J.
    [J]. NEUROLOGY, 2009, 72 (03) : 224 - 231